INTRODUCTION
Activity-dependent changes in the strength of excitatory synapses are thought to be key cellular mechanisms that contribute to the plasticity of neuronal networks underlying learning and memory. Two well-defined cellular models in mammals that measure changes in synaptic strength are long-term potentiation (LTP) and long-term depression (LTD) (Citri and Malenka, 2008; Collingridge et al., 2010; Shepherd and Huganir, 2007) . Like memories, they typically occur in two distinct phases: an early phase that usually depends on modification of preexisting proteins, and a late phase that is more persistent and dependent on the synthesis of new proteins (Citri and Malenka, 2008; Costa-Mattioli et al., 2009; Richter and Klann, 2009; Sutton and Schuman, 2006) . While the importance of de novo protein synthesis in the long-term nature of both memory and its underlying forms of synaptic plasticity has been known for a while, a major difficulty has been the identification of the locally translated proteins directly linked to changes in synaptic strength.
At hippocampal CA1 synapses, several forms of plasticity that are dependent on protein synthesis have been described, including late-phase NMDA receptor (NMDAR)-dependent LTP and LTD (Citri and Malenka, 2008; Collingridge et al., 2010; Klann and Dever, 2004) , and a form of LTD (mGluR-LTD) that relies on the activation of group I metabotropic glutamate receptors, which consist of mGluR1 and mGluR5 (Huber et al., 2000; Oliet et al., 1997) . Activation of either mGluR1 or mGluR5 can induce LTD in the hippocampal CA1 area (Hou and Klann, 2004; Volk et al., 2006) . Whereas both mGluR-LTD and NMDAR-LTD are mediated by endocytosis and decreased surface expression of postsynaptic AMPARs, the two forms of LTD rely on distinct signaling pathways and do not occlude each other (Carroll et al., 1999; Moult et al., 2006; Oliet et al., 1997; Snyder et al., 2001; Waung et al., 2008) . Significantly, in contrast to NMDAR-LTD, where the requirement for protein synthesis is delayed, mGluR-LTD and the associated decreases in surface AMPARs require rapid (within 5-10 min) dendritic protein synthesis (Huber et al., 2000; Snyder et al., 2001 ). The prevailing model is that group I mGluRs trigger rapid synthesis of new proteins in dendrites (referred to as ''LTD proteins'') that function to cause LTD by increasing the rate of AMPAR endocytosis at locally active synapses (Lü scher and Huber, 2010; Waung and Huber, 2009) . A largely remaining challenge, however, is to determine the identity of the LTD proteins. Recent studies have unveiled a few candidate proteins, which in the hippocampus include tyrosine phosphatase STEP (Zhang et al., 2008) , microtubuleassociated protein MAP1B (Davidkova and Carroll, 2007) , and as the leading candidate, activity-regulated cytoskeleton-associated protein Arc/Arg3.1 (Park et al., 2008; Waung et al., 2008) . All three proteins are rapidly synthesized in response to mGluR activation and have been linked to AMPAR endocytosis, which in the case of Arc involves interactions with endophilin A2/3 and dynamin (Chowdhury et al., 2006) . So far, however, it has only been shown for Arc that acute blockade of its de novo synthesis impedes mGluR-LTD and the associated long-term decreases in surface AMPARs (Waung et al., 2008) .
The mechanisms by which mGluRs regulate rapid protein synthesis appear to be multifaceted, involving the regulation of general translation initiation factors (Costa-Mattioli et al., 2009; Richter and Klann, 2009; Waung and Huber, 2009 ), the elongation factor EF2 (Davidkova and Carroll, 2007; Park et al., 2008) , as well as RNA binding proteins, such as the fragile X mental retardation protein (FMRP), the gene product of FMR1 (Bassell and Warren, 2008; Waung and Huber, 2009) . FMRP is thought to function as a repressor of mRNA translation that binds to and regulates the translational efficiency of specific dendritic mRNAs, which include, for instance, Map1b and Arc mRNAs, in response to mGluR activation, and especially mGluR5 (Bassell and Warren, 2008; Costa-Mattioli et al., 2009; Darnell et al., 2011; Dö len et al., 2007; Napoli et al., 2008) . In the absence of FMRP, this control is lost, leading to excessive and dysregulated translation of FMRP target mRNAs and enhanced mGluR-LTD that is protein synthesis independent (Bassell and Warren, 2008; Dö len et al., 2007; Hou et al., 2006; Huber et al., 2002; Nosyreva and Huber, 2006) . Physical interactions between mGluR5 and molecules signaling to the translation machinery have been described, with the Homer scaffolding proteins forming important links to multiple translation control pathways, including initiation and elongation (Giuffrida et al., 2005; Park et al., 2008; Ronesi and Huber, 2008) . mGluR5 has also been linked to the regulation of FMRP through direct binding to and rapid activation (within 1 min) of phosphatase PP2A, which causes dephosphorylation of FMRP and rapid translational upregulation of FMRP target mRNAs (Narayanan et al., 2007) . With regards to mGluR1-mediated signaling at the CA1 synapse, less is known. The mGluR1a isoform, which contains the Homer binding motif, is reportedly absent in hippocampal pyramidal neurons (Ferraguti and Shigemoto, 2006) . Also, the identity of the proteins specifically synthesized upon mGluR1 activation remains elusive.
Here, we examined the requirement of the X-linked mental retardation protein oligophrenin-1 (OPHN1) (Billuart et al., 1998) for mGluR-LTD. OPHN1 is a Rho GTPase-activating protein (Rho-GAP), a negative regulator of Rho GTPases, which, interestingly, besides RhoA, also interacts with Homer 1b/c (Govek et al., 2004) and endophilin A2/3 family members (see Figure 3 ), proteins implicated in mGluR-LTD (Chowdhury et al., 2006; Park et al., 2008; Ronesi and Huber, 2008; Waung and Huber, 2009) . The OPHN1 protein is highly expressed in the brain throughout development, where it is found in neurons of all major regions, including hippocampus and cortex, and is present in axons, dendrites and spines (Govek et al., 2004) . Significantly, loss of OPHN1 function has been causally linked to a syndromic form of mental retardation (MR). Several studies reported the presence of OPHN1 loss-of-function mutations in families with MR associated with cerebellar hypoplasia and lateral ventricle enlargement (Bergmann et al., 2003; des Portes et al., 2004; Philip et al., 2003; Zanni et al., 2005) . Moreover, inactivation of ophn1 in mice recapitulates some of the human phenotypes, such as behavioral and cognitive impairments (Khelfaoui et al., 2007) . At the hippocampal CA3-CA1 synapse, during early development, postsynaptic OPHN1, through its Rho-GAP activity, plays a key role in activity-dependent maturation and plasticity of excitatory synapses (Nadif Kasri et al., 2009), suggesting the involvement of OPHN1 in normal activity-driven glutamatergic synapse development. Findings presented here demonstrate that OPHN1 also plays a critical role in mediating mGluR-LTD in CA1 hippocampal neurons. We find that OPHN1 expression is translationally induced in dendrites of CA1 neurons within 10 min of mGluR activation, and that this response is essential for mGluR-dependent LTD. Acute blockade of new OPHN1 synthesis impedes mGluR-LTD and the associated long-term decreases in surface AMPARs. Interestingly, the rapid induction of OPHN1 expression is primarily dependent on mGluR1 activation, and is independent of FMRP. Importantly, OPHN1's role in mediating mGluR-LTD can be dissociated from its role in basal synaptic transmission (Nadif Kasri et al., 2009) . Regulation of basal synaptic strength requires OPHN1's Rho-GAP activity and association with Homer 1b/c proteins, whereas mGluR-LTD and the associated long-term decreases in surface AMPARs are dependent on OPHN1's interaction with endophilin A2/3. Thus, our data unveil a critical role for rapid OPHN1 synthesis in mGluR-LTD, providing not only further insight into the mechanism and function of mGluR-LTD, but also into the cellular basis by which mutations in OPHN1 could contribute to the behavioral and cognitive deficits in OPHN1 patients.
RESULTS
Group I mGluR Activation Induces Rapid Dendritic Synthesis of OPHN1 Our findings that OPHN1 interacts with Homer 1b/c and endophilin A2/3 (see below), proteins with reported roles in mGluRdependent LTD, prompted us to explore the involvement of OPHN1 in this form of plasticity. We reasoned that if OPHN1 plays a direct role in mGluR-LTD, its protein levels should be rapidly regulated in response to mGluR activation. Therefore, OPHN1 protein expression was examined by immunocytochemistry in CA1 neurons of acute hippocampal slices treated with DHPG, a selective mGluR1/5 agonist, or control vehicle. We observed that DHPG treatment of acute slices leads to a rapid increase in OPHN1 protein levels (within 10 min) in both the soma and dendrites of CA1 neurons ( Figure 1A ). Importantly, this increase was blocked by the protein synthesis inhibitors anisomycin and cycloheximide ( Figure 1A , and data not shown), but not the DNA transcription inhibitor actinomycin D (see Figure S1A available online) , implying that mGluRs trigger new synthesis of OPHN1 protein from pre-existing mRNA. Similar results were obtained by western blot analysis; namely, DHPG treatment of acute hippocampal slices (for 10 min) caused a significant increase in OPHN1 protein levels, and this increase was blocked by anisomycin, but not actinomycin D ( Figure 1B and Figure S1B ). Neither of the two inhibitors affected basal levels of OPHN1 ( Figure 1B and Figure S1B ). In contrast to DHPG, treatment of slices with a chemical induction paradigm for NMDAR-LTD did not trigger an increase in OPHN1 protein levels ( Figure 1C) .
The observed increase in dendritic OPHN1 levels within 10 min of DHPG application could be the result of new OPHN1 synthesis from preexisting mRNA residing in the dendrites. We note that OPHN1 mRNA is present in dendrites of unstimulated (A 1 ) DHPG treatment (100 mM) of acute hippocampal slices increases OPHN1 immunofluorescence (red) in dendrites of CA1 neurons 10 min after DHPG onset. Pretreatment with anisomycin (20 mM, 30 min) blocks DHPG-induced increases of OPHN1. bIII-tubulin immunoreactivity (green) indicates the presence of dendrites. Scale bar represents 50 mm. s.p., stratum pyramidale; s.r., stratum radiatum. (A 2 ) Quantification of OPHN1 immunofluorescence in dendrites. Mean OPHN1 fluorescence intensity was expressed as percentage of control. n = 27-36 slices (40 mm) from four to five animals per condition, *p < 0.01 (unpaired t test), as compared with control. Error bars represent SEM in all panels. (B 1 ) Western blot of OPHN1 in acute hippocampal slices (CA1 regions) from rats pretreated with anisomycin (20 mM) or control vehicle for 30 min prior to DHPG (100 mM, 10 min) or ACSF treatment. g-tubulin was used as loading control. (B 2 ) Mean OPHN1 levels in drug treated slices expressed as percentage of control treated slices. OPHN1 levels were normalized to g-tubulin levels in the same sample. n = 3-6 slices (400 mm) from three to six animals per condition. *p < 0.01 (unpaired t test), as compared with control. (C) Western blots of OPHN1 in acute hippocampal slices (CA1 regions) from rats treated with DHPG (100 mM, 10 min), NMDA (20 mM, 3 min), or ACSF. ERK2 was used as loading control. NMDA treatment does not increase OPHN1 levels; n = 3 slices (400 mm) from three animals; p > 0.05. hippocampal neurons ( Figure S2 ). Alternatively, this could be due to rapid transport of OPHN1 from the cell body. To distinguish between these two possibilities, we determined whether DHPG increases OPHN1 protein levels in isolated dendrites. To this end, slices in which the CA1 pyramidal neuron soma had been mechanically severed from the dendrites were treated with DHPG, or control vehicle, for 10 min. DHPG effectively increased OPHN1 protein levels in the isolated dendrites (Figure 1D) , implying that OPHN1 is locally synthesized in dendrites. Finally, to determine whether mGluR activation elicits synaptic synthesis of OPHN1, we prepared hippocampal synaptoneurosomes ( Figure 1E ), and incubated them for 15 min with DHPG or control vehicle. Western blot analysis revealed an increase in OPHN1 protein levels in DHPG-treated synaptoneurosomes, which was blocked by preincubation of the synaptoneurosomes with anisomycin ( Figure 1E ). Together, these data provide evidence for mGluR-induced rapid dendritic synthesis of OPHN1 protein in CA1 hippocampal neurons.
DHPG-Induced Rapid Increase in OPHN1 Expression
Depends on mGluR1 Activation and Occurs in the Absence of FMRP Group I mGluRs consist of two subtypes, mGluR1 and mGluR5, and both of these receptors contribute to the induction of mGluR-LTD in the CA1 hippocampal area (Hou and Klann, 2004; Volk et al., 2006) . To determine which of the group I mGluR subtype(s) is responsible for the rapid DHPG-induced increase in OPHN1, we applied specific mGluR1 or mGluR5 antagonists (LY367385 and MPEP, respectively) to acute hippocampal slices, 30 min before the addition of DHPG. As expected, OPHN1 levels were elevated within 10 min upon application of DHPG alone. This elevation, however, was blocked when LY367385 was present ( Figure 1F and Figure S1C ). In contrast, MPEP did not appreciably affect the DHPG-induced increase in OPHN1 levels ( Figure 1F and Figure S1C ). Treatment of slices with either LY367385 or MPEP alone did not alter basal levels of OPHN1 (data not shown). These data indicate that the rapid increase of OPHN1 largely depends on activation of mGluR1, rather than mGluR5.
A key player in the regulation of mGluR-stimulated protein translation is the FMRP protein. In the absence of FMRP, excess basal translation and loss of mGluR-induced translation of selected mRNAs, including those encoding MAP1B and Arc, have been reported (reviewed in Bassell and Warren, 2008) . Although loss of FMRP has generally been linked to excessive mGluR5 signaling (Bassell and Warren, 2008; Dö len et al., 2007; Osterweil et al., 2010) , at this point, however, a role for FMRP in the regulation of OPHN1 synthesis could not be excluded. To assess this, we prepared acute hippocampal slices from Fmr1 knockout (KO) mice and corresponding wild-type mice, and stimulated them with DHPG or control vehicle. OPHN1 expression in control vehicle-treated slices was not considerably different between wild-type and Fmr1 KO conditions ( Figure 1G ). Moreover, DHPG treatment of Fmr1 KO derived slices resulted in a rapid increase in OPHN1 protein levels to an extent similar as seen in wild-type DHPG-treated slices ( Figure 1G ). Thus, loss of FMRP does neither affect basal OPHN1 levels nor the mGluR-induced upregulation of OPHN1, implying that the synthesis of OPHN1 in hippocampal neurons is not subject to FMRP regulation.
OPHN1 Knockdown Impairs mGluR-LTD
Based on our findings that OPHN1 becomes rapidly upregulated in dendrites of CA1 neurons in response to mGluR activation, we next investigated whether OPHN1 is required for mGluRmediated LTD at CA1 synapses. To this end, we utilized a lentivirus that coexpresses EGFP and a short-hairpin (sh) RNA (OPHN1#2) to knockdown OPHN1 mRNA and protein (Nadif Kasri et al., 2009 ). The OPHN1#2 shRNA significantly reduced endogenous OPHN1 protein levels in hippocampal neurons, whereas a control scrambled shRNA (scr#1) was ineffective (Figure 2A) (Nadif Kasri et al., 2009 ). We opted for this approach because it allows for spatio-temporal regulation of endogenous OPHN1 expression. RNAi-mediated temporal knockdown of OPHN1 selectively in CA1 neurons has no detectable effect on presynaptic function and it minimizes the possibility of developmental compensations (Nadif Kasri et al., 2009 ); both of these events could affect the induction and expression of mGluR-LTD (Khelfaoui et al., 2007) .
CA1 neurons in cultured hippocampal slices were infected with the OPHN1#2 shRNA containing lentivirus, and 8 to 10 days post-infection the magnitude of mGluR-dependent (D 1 ) Representative differential interference contrast (DIC) (left) and OPHN1 immunofluorescence (middle) images from CA1 regions where a cut severed the dendrites from the pyramidal cell layer. bIII-tubulin immunoreactivity (right) indicates the presence of dendrites. Top: vehicle treated; bottom: DHPG treated (100 mM, 10 min). Scale bar represents 20 mm. (D 2 ) Quantification of OPHN1 immunofluorescence in dendrites that were severed (cut) from the soma and in neighboring uncut dendrites, akin as in A 2 . n = 5 slices (40 mm) from five animals per condition. *p < 0.01 (unpaired t test), as compared with control. Quantification of bIII-tubulin immunofluorescence reveals no difference in bIII-tubulin levels in cut and uncut dendrites treated with DHPG or control vehicle; p > 0.05. (E 1 ) Western blots of synaptoneurosome preparation (SN) reveals enrichment of PSD-95 and synaptophysin (Syn) and a reduction in bIII-tubulin and histone H3 (H3) in comparison to whole homogenate (Input) or supernatant (Sup). (E 2 ) Western blot of synaptoneurosome preparation pretreated with anisomycin (20 mM) or control vehicle 30 min prior to DHPG treatment (100 mM, 15 min). (E 3 ) Mean OPHN1 levels in drug treated synaptoneurosomes expressed as percentage of control vehicle treated synaptoneurosomes. OPHN1 levels were normalized to ERK2 levels in the same sample. n = 3 independent preparations from three animals. *p < 0.01 (unpaired t test), as compared with control. (F 1 ) Western blot of OPHN1 in acute hippocampal slices (CA1 regions) from rats pretreated with LY367385 (100 mM), MPEP (10 mM), or control vehicle 30 min before DHPG treatment (100 mM, 10 min). ERK2 was used as loading control. (F 2 ) Mean OPHN1 levels are presented as in (E 1 ). n = 3-6 slices (400 mm) from three to six animals per condition. *p < 0.01 (unpaired t test), as compared with control. (G 1 ) Western blot of OPHN1 in acute hippocampal slices (CA1 regions) from 4-to 6-week-old Fmr1 KO mice and corresponding WT mice treated with DHPG (100 mM, 10 min) or ACSF. bIII-tubulin was used as loading control. (G 2 ) Mean OPHN1 levels are presented as above. n = 4 slices (400 mm) from four animals per condition. *p < 0.01 (unpaired t test), as compared with control treated WT slices.
LTD induced in control uninfected and OPHN1#2 shRNA infected cells with bath application of DHPG (100 mM, 5 min) was examined. Consistent with previous studies (Huber et al., 2000 Volk et al., 2006) , DHPG caused a depression of AMPAR-mediated synaptic transmission in control cells, which is protein translation dependent, and, notably, is attenuated by blockade of mGluR1 with LY367385 throughout the experiment (Figure 2B and Figures S3A and S3B) . When compared to mGluR-LTD induced in simultaneously recorded control cells, knockdown of OPHN1 greatly reduced the magnitude of mGluR-LTD. A depression in AMPAR-mediated synaptic transmission of approximately 40% was observed in control cells versus 10% in OPHN1#2 shRNA expressing cells, 30-35 min after DHPG application ( Figure 2B ). To ensure that this effect was specifically caused by impaired OPHN1 expression, we performed rescue experiments by using OPHN1 cDNA that is resistant to OPHN1#2 shRNA-mediated RNAi (Nadif Kasri et al., 2009) . The levels of OPHN1 expression in hippocampal neurons coexpressing RNAi-resistant OPHN1
WT and OPHN1#2 shRNA were restored to normal levels ( Figure 2A ), and, most importantly, the magnitude of mGluR-LTD was comparable to that of control neurons ( Figure 2C ). Thus, knockdown of OPHN1 impairs mGluR-LTD. One possible explanation for the impaired mGluR-LTD is that it is due to reduction in basal synaptic strength, as OPHN1 RNAi depresses glutamatergic synaptic transmission ( Figure 2B , left panel before DHPG application, and see Figure 4A) , thereby occluding LTD. Alternatively, however, activitydependent OPHN1 induction could play a critical role in mediating mGluR-LTD independent of its effects on basal synaptic strength. Distinguishing between these two possibilities requires a dissociation of OPHN1's role in regulating basal synaptic transmission and mGluR-LTD. To determine whether such dissociation can be achieved, we resorted to OPHN1 mutants and synthetic blocking peptides that selectively disrupt the interaction between OPHN1 and OPHN1-binding partners present in dendritic spines; the synaptic effects of these mutants and peptides were subsequently tested.
Selective Disruption of OPHN1 Interactions with Its Postsynaptic Binding Partners Homer 1b/c, RhoA, and Endophilin A2/3 We previously described an interaction between OPHN1 and the small GTPase RhoA, as well as Homer 1b/c, at the postsynaptic site of hippocampal neurons (Govek et al., 2004) . We showed that OPHN1 through its Rho-GAP domain represses the RhoA/ Rho-kinase pathway in spines of CA1 neurons (Govek et al., 2004) , and generated an OPHN1 mutant, OPHN1
GAP (R409Q) that abolishes its Rho-GAP activity (Nadif Kasri et al., 2009 ; see Figure 3A ). This mutant failed to rescue the OPHN1 RNAievoked defects in structural and functional maturation of glutamatergic synapses (Nadif Kasri et al., 2009) . With regards to OPHN1 and Homer 1b/c, we demonstrated that these proteins physically interact and colocalize in dendritic spines (Govek et al., 2004 ; Figure S4A ); the importance of this association remained however unknown. Introduction of mutations in the consensus Homer binding motif located in the N terminus of OPHN1 disrupted its interaction with Homer 1b/c (OPHN1 Hom ; Figures 3A and 3B) (Govek et al., 2004) . As an additional tool to acutely disrupt this interaction, we designed a peptide consisting of an OPHN1 sequence that contains the Homer ligand domain (pep-OPHN1 Hom ; Figure 3C ). The peptide was made cell permeable by addition of the human immunodeficiency virus-type 1 Tat sequence. We found that this peptide disrupts the OPHN1-Homer 1b/c interaction ( Figure 3C ), whereas a control peptide containing three amino acid substitutions in the binding motif did not (pep-cont Hom , Figure 3C ). Notably, pep-OPHN1
Hom did not disrupt the association between Homer 1b/c and dynamin-3, nor between Homer 1b/c and mGluR5 ( Figures S4B and S4C ). A third class of proteins we found to associate with OPHN1 are members of the endophilin A family, which include endophilin A1, A2, and A3 (Kjaerulff et al., 2011) . In previous studies, we and others demonstrated a direct interaction between OPHN1 and endophilin A1 (Endo1) (Khelfaoui et al., 2009; Nakano-Kobayashi et al., 2009) , which is predominantly expressed in presynaptic nerve terminals, and showed that this interaction is critical for OPHN1's presynaptic function in synaptic vesicle retrieval ). The endophilin A2 (Endo2) and endophilin A3 (Endo3) proteins, on the other hand, are enriched in postsynaptic compartments and have been implicated in the regulation of AMPAR endocytosis in hippocampal neurons (Chowdhury et al., 2006) . Given that all three family members are highly conserved, containing an N-terminal N-BAR (Bin/Amphiphysin/Rvs) domain and a C-terminal SH3 domain (Kjaerulff et al., 2011) , we tested whether OPHN1 also interacts with Endo2 and 3. We found that this is indeed the case (Figures 3D and 3E and Figures S5A and S5B) , and that the interaction is mediated via binding of the third proline rich domain (PRD3) of OPHN1 to the SH3 domain of Endo2/3 ( Figure 3D and Figure S5B , data not shown). Moreover, coimmunoprecipitation experiments revealed that treatment of hippocampal slices with DHPG leads to increased binding of OPHN1 to Endo2/3, which, notably, is protein synthesis dependent ( Figure 3E ). Mutations in the PRD3 of OPHN1 (PRD3*) disrupt its association with Endo2/3 (OPHN1 Endo ; Figure 3D and Figure S5B ). Specific disruption of the OPHN1-Endo2/3 interaction was also achieved by employing a peptide consisting of an OPHN1 sequence that contains the endophilin ligand domain (pep-OPHN1 Endo ), but not a control peptide containing three amino acid substitutions in the binding motif (pep-cont Endo ) ( Figure 3F and Figures S5C-S5E) . Importantly, all three OPHN1 mutants, OPHN1 GAP , OPHN1
Hom
, and OPHN1 Endo still resided in spines, as revealed by two-photon microscopy of CA1 neurons of hippocampal slices ( Figure S5F ). Also, treatment of slices with either pep-OPHN1 Hom or pep-OPHN1 Endo did not affect the localization of OPHN1 in spines (data not shown).
Regulation of Basal Synaptic Transmission by OPHN1
Requires Its Rho-GAP Activity and Interaction with Homer 1b/c, but Not Endo2/3 To determine whether disruption of any of the above-described interactions could dissociate OPHN1's role in regulating basal synaptic transmission and mGluR-LTD, we began by examining the synaptic effects of replacing endogenous OPHN1 with one of the three OPHN1 mutants using a lentivirus-mediated molecular replacement strategy (Nadif Kasri et al., 2009) . To this end, lentiviral vectors that coexpress OPHN1#2 shRNA and RNAi-resistant OPHN1 GAP , OPHN1 Hom , or OPHN1 Endo fused to EGFP
were generated. We first tested whether any of these mutants could rescue the decrease in basal synaptic strength caused by OPHN1 RNAi in CA1 neurons ( Figures 4A and 4F ). Coexpression of OPHN1 WT with OPHN1#2 shRNA restored basal synaptic strength to normal ( Figures 4B and 4F ). In contrast, coexpression of OPHN1 GAP or OPHN1 Hom failed to rescue the OPHN1#2 shRNA-evoked defects in AMPAR-and NMDAR-mediated transmission ( Figures 4C, 4D, and 4F) . Interestingly, coexpression of OPHN1
Endo rescued the defects in basal synaptic transmission akin to OPHN1 WT ( Figures 4E and 4F) . Notably, all OPHN1 mutants were expressed at similar levels ( Figure S6 ). These results indicate that OPHN1's Rho-GAP activity and interaction with Homer 1b/c, but not Endo2/3, are important for regulating basal synaptic strength.
OPHN1 Mediates mGluR-Dependent LTD through Interaction with Endo2/3 Next, we examined the abilities of OPHN1 GAP , OPHN1
Hom
, and OPHN1
Endo to rescue the deficit in mGluR-LTD caused by OPHN1 knockdown, using the above described replacement strategy. CA1 neurons coexpressing OPHN1#2 shRNA and OPHN1 GAP , or OPHN1 Hom , displayed impaired mGluR-LTD to an extent similar to that seen in cells expressing OPHN1#2 shRNA alone ( Figures 5A, 5B, and 5D ). Most interestingly, neurons coexpressing OPHN1#2 shRNA and OPHN1 Endo , although having normal basal synaptic transmission, showed a defect in mGluR-LTD ( Figures 5C and 5D ). These results indicate that the effects of OPHN1 on basal synaptic transmission and mGluR-LTD are dissociable and involve distinct protein-protein interactions, with the interaction between OPHN1 and Endo2/3 being critical for its role in mGluR-LTD.
To corroborate and extent these findings, we next investigated the impact of pep-OPHN1
Endo and pep-OPHN1 Hom , which disrupt OPHN1-Endo2/3 and OPHN1-Homer interactions, respectively, on mGluR-LTD in acute hippocampal brain slices.
Postsynaptic infusion of pep-OPHN1
Endo through a whole-cell patch pipette (30 min prior to DHPG application) significantly reduced mGluR-LTD compared to the control peptide (Figure 6A) . Infusion of CA1 neurons with pep-OPHN1 Endo had no effect on basal synaptic transmission ( Figure 6B ). These findings indicate that the actions of pep-OPHN1 Endo are rapid and corroborate our results obtained with the OPHN1 Endo mutant.
When pep-OPHN1 Hom was included in the pipette, mGluR-LTD and baseline EPSC amplitudes were comparable to those of the control peptide ( Figures 6C and 6D ). Of note, the lack of an effect on basal synaptic transmission upon short-term disruption of the OPHN1/Homer 1b/c interaction with pep-OPHN1 Hom is consistent with previous findings that prolonged, but not shortterm, knockdown of OPHN1 reduces basal synaptic transmission (Nadif Kasri et al., 2009). Together, our data indicate that OPHN1 plays a crucial role in mediating mGluR-LTD, and that OPHN1's interaction with Endo2/3, but not Homer 1b/c proteins, is critical for this event.
Previous studies have shown that activation of group I mGluRs leads to persistent decreases in surface AMPAR expression levels that mediate LTD (Snyder et al., 2001; Waung et al., 2008) . Since the OPHN1-Endo2/3 interaction is critical for mGluR-LTD, we directly tested whether it is important for mGluR-induced changes in surface AMPAR expression and endocytosis. To quantify AMPAR surface levels and the degree of AMPAR internalization, we employed a biochemical method to crosslink surface-only AMPAR subunits. Acute slices of hippocampal area CA1 were preincubated with no peptide, pep-cont Endo or pep-OPHN1 Endo . The CA1 slices were then treated with DHPG or control vehicle (for 10 min), and 50 min later incubated with the membrane-impermeant cross-linking reagent bis (sulfosuccinimidyl) suberate (BS 3 ). Western blotting with an anti-GluR1 antibody revealed a decrease in cell-surface GluR1 expression and an increase in internalized GluR1 levels 1 hr after DHPG treatment in the no peptide and control peptide preincubated CA1 slices ( Figures S7A and S7B ). The DHPG-induced decrease in cell-surface GluR1 expression and increase in internal GluR1 levels were, however, significantly attenuated in CA1 slices that were preincubated with pep-OPHN1 Endo ( Figures S7A and S7B ). Of note, the pep-OPHN1 Endo peptide did not affect basal levels of surface GluR1 ( Figures S7A  and S7B ). Similar results were obtained for the GluR2 AMPAR subunit (data not shown). To corroborate these findings, we undertook an immunofluorescence approach to measure AMPAR surface levels. Cultured hippocampal neurons, preincubated with no peptide, pep-cont Endo or pep-OPHN1 Endo , were treated with DHPG or control vehicle (for 10 min), and 1 hr after treatment labeled with an N-terminal directed anti-GluR1 antibody. Consistent with our above biochemical data, pep-OPHN1 Endo did not affect basal levels of surface GluR1, but attenuated the decrease of surface GluR1 observed 1 hr post-DHPG ( Figures 6E and 6F) . We conclude that the OPHN1-Endo2/3 interaction plays a key role in mGluR-triggered longterm decreases in surface AMPARs.
Acute Blockade of mGluR-Induced OPHN1 Synthesis Impedes mGluR-LTD Our data showed that mGluR activation triggers rapid synthesis of OPHN1 and that OPHN1 mediates mGluR-LTD and the associated long-term decreases in surface AMPAR expression through its interaction with Endo2/3. The latter experiments, however, did not address whether new synthesis of OPHN1 in response to mGluR activation is required for these events. To prevent/block mGluR-elicited new synthesis of OPHN1, we employed a previously described siRNA (Ophn1#2 siRNA) (Govek et al., 2004) . We reasoned that acute delivery of Ophn1#2 siRNA should only prevent the DHPG-induced rapid increase in OPHN1 expression, without affecting basal levels of OPHN1, given that OPHN1 is a relatively stable protein and there is very little OPHN1 synthesis for a period of up to several hours in the absence of DHPG ( Figure S8A , data not shown). To test this, Ophn1#2 siRNA or a nontargeting Ophn1 mismatch siRNA was introduced into cultured hippocampal neurons using lipid mediated transfer. Thirty minutes after siRNA delivery, neurons were treated with DHPG or control vehicle for 10 min, and analyzed by confocal microscopy ( Figure 7A ). Of note, we know from experiments using fluorescently labeled siRNAs that the siRNAs are effectively taken up by the cells within a 30 min time frame ( Figures  S8B-S8D) . DHPG stimulation over a period of 10 min induced a significant increase in dendritic OPHN1 levels in neurons exposed to the mismatch siRNA, and, importantly, this increase was abolished in neurons subjected to the Ophn1#2 siRNA ( Figures 7A and 7B, DHPG) . Notably, incubation of neurons with Ophn1#2 siRNA for 40 min in the absence of DHPG did not affect the basal levels of OPHN1 ( Figures 7A and 7B, control) . Thus, these data indicate that acute delivery of Ophn1#2 siRNA can be used to prevent/block new OPHN1 synthesis induced by DHPG.
Using the Ophn1#2 and mismatch siRNAs, we then investigated the effects of blocking rapid OPHN1 synthesis on mGluR-induced decreases in surface AMPARs. Thirty minutes after delivery of the siRNAs, neurons were treated with DHPG or control vehicle (for 10 min), and labeled as described above with an N-terminal directed anti-GluR1 antibody 1 hr posttreatment. Ophn1#2 siRNA did not affect basal levels of surface GluR1, however, it hampered the decrease of surface GluR1 observed 1 hr after DHPG treatment ( Figures 7C and 7D ). These data indicate that rapid OPHN1 synthesis is important for the mGluR-induced persistent decreases in surface AMPAR expression.
Next, we tested the effect of blocking rapid OPHN1 synthesis on basal synaptic transmission and DHPG-induced mGluR-LTD. We introduced Ophn1#2 siRNA, or mismatch siRNA, into CA1 neurons of acute hippocampal slices via whole-cell recording pipettes, and recorded evoked ESPCs. Similar to the mismatch siRNA, Ophn1#2 siRNA did not affect basal synaptic transmission ( Figure 7E ). To induce LTD, we subjected the slices to DHPG bath application (100 mM, 5 min) 30 min after breaking into the cells. LTD was observed in cells infused with control mismatch siRNA (Figures 7F-7H ). In contrast, DHPG failed to induce LTD in neurons infused with Ophn1#2 siRNA. Note, all LTD experiments were performed within the same slice using two simultaneous patch-clamp recordings of neighboring CA1 cells; each pipette was filled with one of the siRNAs. Together, these data indicate that rapid synthesis of OPHN1 is necessary for mGluR-LTD.
Noteworthy, previous studies demonstrated that mGluR-LTD persists in the absence of protein synthesis in Fmr1 KO mice (Hou et al., 2006; Nosyreva and Huber, 2006) . Our data indicate that mGluR-induced OPHN1 synthesis is independent of FMRP ( Figure 1G ), raising the question as to whether mGluR-LTD in Fmr1 KO mice still requires OPHN1 synthesis. To address this, we introduced Ophn1#2 siRNA, or mismatch siRNA, into CA1 neurons of acute hippocampal slices prepared from Fmr1 KO and corresponding wild-type mice, and subjected the slices to DHPG bath application 30 min after breaking into the cells. LTD was observed in both wild-type and Fmr1 KO cells infused with the control mismatch siRNA ( Figures 8A and 8B ), which consistent with previous reports was protein synthesis dependent in wild-type, but not Fmr1 KO neurons (data not shown). Interestingly, whereas DHPG-induced LTD was inhibited in wild-type neurons infused with Ophn1#2 siRNA, LTD was not affected in Fmr1 KO neurons infused with the Ophn1#2 siRNA ( Figures 8A and 8B ). These data indicate that OPHN1 synthesis is required for mGluR-LTD in wild-type, but not Fmr1 KO mice. Likely, the elevated/aberrant protein synthesis caused by loss of FMRP can compensate for the requirement of new synthesis of OPHN1.
DISCUSSION
A common feature for mGluR-LTD in many brain regions is the reliance on rapid and local protein synthesis (Lü sher and Huber, 2010; Waung and Huber, 2009 ). The identities of the newly synthesized proteins that mediate LTD, however, remain largely elusive, with Arc/Arg3.1 being the leading candidate 'LTD protein' in the hippocampal CA1 area (Park et al., 2008; Waung and Huber, 2009; Waung et al., 2008) . Our study identifies the X-linked mental retardation protein, OPHN1, as a new molecule that is rapidly synthesized upon activity and is required for mGluR-LTD in the hippocampus. Importantly, the role of OPHN1 in mediating mGluR-LTD can be molecularly dissociated from its role in basal AMPAR-mediated synaptic transmission (Nadif Kasri et al., 2009) . Whereas the former requires OPHN1's interaction with Endo2/3, the latter requires OPHN1's Rho-GAP activity and interaction with the Homer 1b/c proteins ( Figure 8C ).
Group I mGluR Activation Triggers Rapid and Dendritic OPHN1 Synthesis in an mGluR1 Dependent and FMRP Independent Manner
Our results provide several lines of evidence for rapid dendritic synthesis of OPHN1 in response to group I mGluR stimulation in the hippocampal CA1 area. First, activation of group I mGluRs triggers a fast upregulation (within 10 min) of OPHN1 in hippocampal CA1 neurons, in a process that relies on protein synthesis from preexisting mRNA. Second, the rapid upregulation of OPHN1 not only occurs in dendrites of intact hippocampal CA1 neurons, but also in isolated dendrites that have been severed from their cell bodies, implying that the increased OPHN1 levels in dendrites are not caused by soma-mediated synthesis and transport into the dendrites. Finally, rapid protein synthesis dependent upregulation of OPHN1 is also evident in synaptoneurosomes upon group I mGluR activation. Notably, stimuli that elicit NMDAR-dependent LTD or -LTP, or spontaneous synaptic activity, do not trigger an increase in OPHN1 protein expression (this study and Nadif , suggesting that OPHN1 induction is rather specific for mGluRinducing stimuli.
Our results further reveal that the mechanism by which mGluR activity triggers rapid OPHN1 synthesis involves the activation of mGluR1, rather than mGluR5. This is of particular interest, as little is known about how mGluR1 is molecularly linked to the translational machinery, and, most importantly, what its relevant targets are in the hippocampal CA1 area (Waung and Huber, 2009 ). To our knowledge, OPHN1 is the first protein shown to be rapidly induced by mGluR activity in an mGluR1 dependent manner. In the case of, for instance, STEP, its induction occurs in an mGluR5 dependent manner (Zhang et al., 2008) . Intriguingly, our results also indicate that the synthesis of OPHN1 associated with mGluR activation is FMRP independent. In contrast to Arc and MAP1B (Hou et al., 2006; Park et al., 2008) , the basal level of OPHN1 is not elevated in the hippocampus of Fmr1 KO mice and it can be increased upon mGluR stimulation. Hence, OPHN1 is not likely a target for FMRP-mediated repression. With regard to this finding, and in light of our finding that OPHN1 synthesis is dependent on mGluR1 activation, it is noteworthy that the function of FMRP in mGluR-stimulated protein synthesis has been linked mainly to mGluR5 (Bassell and Warren, 2008; Dö len et al., 2007; Osterweil et al., 2010) . For instance, the excessive protein synthesis observed in Fmr1 KO hippocampus can be corrected by genetic reduction or acute pharmacological inhibition of mGluR5 (Dö len et al., 2007; Osterweil et al., 2010) . Together, our data unveil a potential FMRP-independent pathway linking mGluR1 to the regulation of OPHN1 synthesis.
mGluR-Induced OPHN1 Mediates Persistent Downregulation of Surface AMPARs and LTD Via Interaction with Endo2/3 To determine whether OPHN1 synthesis is required for mGluR-LTD, we used siRNAs to specifically prevent/block the mGluRinduced rapid increase in OPHN1 levels. Our data show that acute blockade of OPHN1 induction impedes mGluR-LTD, indicating that OPHN1 synthesis is necessary for mGluR-LTD. Consistent with previous reports that mGluR-LTD is mediated by a persistent reduction in surface AMPARs (Moult et al., Synaptic activity through NMDAR activation drives OPHN1 into dendritic spines, where it forms a complex with Homer 1b/c proteins and through its Rho-GAP activity locally suppresses RhoA activity and remodels actin filaments. Via its actions on Homer 1b/c and RhoA, OPHN1 regulates activity-dependent AMPAR synaptic stabilization, as well as maintenance of spine structure, thereby permitting the maturation and strengthening of CA1 excitatory synapses (Nadif Kasri et al., 2009 ). Right panel: OPHN1 in mGluR-LTD. Activation of mGluR1 triggers a rapid increase in dendritic OPHN1 synthesis. mGluR1-induced OPHN1 then engages in a complex with endophilin A2/3 and dynamin to enhance AMPAR internalization, thereby mediating persistent decreases in surface AMPARs and LTD.
2006; Snyder et al., 2001; Waung et al., 2008) , we find that acute blockade of OPHN1 synthesis blocks the downregulation of surface AMPARs one hour after mGluR activation. Together, these data imply that mGluR-induced OPHN1 mediates LTD by promoting the internalization of AMPARs.
Further support for these results, and mechanistic insight into how OPHN1 induction could regulate AMPAR endocytosis during mGluR-LTD, were provided by our finding that OPHN1 interacts with N-BAR domain-containing Endo2/3 core components of the postsynaptic clathrin-dependent endocytic machinery (Chowdhury et al., 2006) . Interestingly, our data show that mGluR stimulation enhances OPHN1 association with Endo2/3 in a protein synthesis dependent manner. And importantly, disruption of the OPHN1-Endo2/3 interaction impedes both mGluR-elicited persistent decreases in surface AMPARs and LTD. Notably, these effects are not attributable to some general disruption of AMPARs or the machinery that controls their trafficking, because disruption of the OPHN1-Endo2/3 interaction does not affect basal AMPAR levels or basal synaptic function. Thus, these data imply that the downregulation of surface AMPARs during mGluR-LTD requires OPHN1 induction and its ability to bind Endo2/3. Likely, OPHN1 induced upon mGluR activation, via the regulation of Endo2/3 0 s activities, increases the rate of AMPAR endocytosis.
While our data demonstrate a requirement for OPHN1 synthesis in mGluR-LTD, previous studies have shown that newly synthesized Arc protein is also required for this process (Waung et al., 2008) , implying that both mGluR-induced OPHN1 and Arc, and perhaps other proteins, such as MAP1B and STEP (Davidkova and Carroll, 2007; Zhang et al., 2008) , are likely to contribute jointly to LTD, and, moreover, that mGluR1/5 must coordinate the various translational control mechanisms involved. Of particular interest is that Arc also interacts with Endo2/3 and this interaction is important for the role of Arc in AMPAR trafficking (Chowdhury et al., 2006) . Of note, OPHN1 and Arc interact with different regions of Endo2/3, with OPHN1 binding to the SH3 domain of Endo2/3, and Arc to the C terminus of the N-BAR domain of Endo2/3 (Chowdhury et al., 2006) . Therefore, it is possible that newly synthesized OPHN1 and Arc cooperate at the level of Endo2/3 to promote mGluR-driven AMPAR endocytosis, either by regulating distinct aspects of Endo2/3 function or by promoting/engaging a common mechanism, at least under wild-type conditions. Importantly, a different mode of mGluR-LTD regulation seems to occur upon loss of FMRP. Indeed, previous studies demonstrated that mGluR-LTD in Fmr1 KO mice is distinctly different from that in wild-type mice. For instance, whereas mGluR-LTD in wild-type mice is protein synthesis dependent, it persists in the absence of protein synthesis in Fmr1 KO mice (Hou et al., 2006; Nosyreva and Huber, 2006) . Consistent with this, our data show that acute blockade of OPHN1 synthesis does not affect mGluR-LTD in Fmr1 KO mice, albeit it clearly blocks mGluR-LTD in wild-type mice, indicating that OPHN1 synthesis is required for mGluR-LTD under wild-type conditions but not upon loss of FMRP. We conjecture that the elevated/aberrant protein synthesis caused by loss of FMRP can compensate for the requirement of new synthesis of OPHN1 and likely other proteins as well.
OPHN1 Serves Multiple Functions at the Hippocampal CA1 Synapse
In a previous study, we demonstrated that postsynaptic OPHN1 controls the maturation and strengthening of CA1 excitatory synapses in response to synaptic activity and NMDAR activation (Nadif Kasri et al., 2009) . Combined with our current work, this indicates that OPHN1 carries out multiple functions at the hippocampal CA1 synapse. Our data show that the effects of OPHN1 on mGluR-LTD and basal synaptic strength are dissociable and involve distinct protein-protein interactions. As discussed above, disruption of the OPHN1-Endo2/3 interaction blocks mGluR-induced LTD and the associated long-term decreases in surface AMPARs. Yet, disruption of the OPHN1-Endo2/3 interaction does not interfere with basal synaptic function, or NMDAR-dependent LTP (data not shown), indicating that OPHN1 regulation of mGluR-LTD via its interaction with Endo2/3 is independent of its role in potentiating synaptic strength. We posit that OPHN1, upon induction by mGluR activity, engages in a complex with Endo2/3 to enhance AMPAR internalization, thereby mediating persistent decreases in surface AMPARs and LTD.
On the other hand, we find that OPHN1's interaction with Homer 1b/c is not required for its role in mGluR-LTD, but that this interaction, as well as the Rho-GAP activity of OPHN1, is important for its role in regulating basal synaptic function. The GAP activity of OPHN1 toward RhoA is also required for its role in controlling structural and functional changes during LTP (Nadif Kasri et al., 2009 ). As to how OPHN1 could mediate the strengthening of synapses via interactions with Homer 1b/c and RhoA, we previously demonstrated that stabilizing AMPARs at the synapse prevents the defects in synaptic structure and function caused by extended OPHN1 knockdown (Nadif Kasri et al., 2009 ). Hence, a conceivable scenario is that OPHN1 via its interactions with Homer 1b/c and RhoA regulates the stabilization of AMPARs at the synapse, thereby controlling activity dependent maturation and strengthening of synapses ( Figure 8C ).
Together, these findings point to a multifunctional role for OPHN1 at CA1 synapses. Independent of its role in activity driven glutamatergic synapse development, regulated OPHN1 synthesis plays a critical role in mGluR-dependent LTD. Thus, it is conceivable that on one hand OPHN1 might play an important role in synapse maturation and circuit wiring during early development, on the other hand the regulated OPHN1 synthesis could operate during adulthood to weaken synapses in response to behaviorally relevant stimuli. In light of the previously reported role for LTD in behavioral flexibility and novelty detection (Kemp and Manahan-Vaughan, 2007; Lü scher and Huber, 2010) , and the association of OPHN1 loss of function with altered social behavior and novelty-driven hyperactivity (des Portes et al., 2004; Khelfaoui et al., 2007; Zanni et al., 2005) , the requirement for OPHN1 in mGluR-LTD could offer an intriguing potential explanation for some of the behavioral deficits exhibited by OPHN1 patients.
EXPERIMENTAL PROCEDURES
DNA constructs, virus production, siRNAs, peptides, and fluorescence in situ hybridization assay are included in Supplemental Experimental Procedures.
Acute Brain Slices and Hippocampal Slice and Dissociated Cultures
Acute slices were prepared from 21-30-day-old rats (Sprague-Dawley), or 3.5-6-week-old Fmr1 KO mice (FVB.129P2-Fmr1 tm1Cgr /J) and corresponding littermates. Briefly, animals were anesthetized with isoflurane and decapitated; the brains were quickly removed and chilled in ice-cold dissection buffer. Coronal slices (400 mm) were cut in dissection buffer using a VT-1000S vibratome (Leica) and transferred to a storage chamber containing artificial cerebrospinal fluid (ACSF) for 30 min at 32 C. Slices were then incubated at RT for 1-3.5 hr prior to use in experiments. See Supplemental Experimental Procedures for details on buffers, and for the preparation, infection, and transfection of hippocampal slice and dissociated cultures.
Biochemical Analysis, AMPA Receptor Surface Labeling, and Immunofluorescence Western blotting, pull-down assays, coimmunoprecipitations, synaptoneurosome preparation, AMPAR surface labeling, and immunofluorescence were performed largely as described (Govek et al., 2004; Nadif Kasri et al., 2009; Park et al., 2008; Waung et al., 2008) . See Supplemental Experimental Procedures for details.
Cut Dendrite Experiments
Dendrites in CA1 region of hippocampal slices were cut at the border of the stratum pyramidale and stratum radiatum with a microdissection knife under a dissection microscope (Huber et al., 2000) . Ten minutes after treatment with DHPG or control vehicle (ACSF), slices were fixed, embedded in agarose (3%), resectioned at 40 mm, and processed for immunofluorescence staining with anti-OPHN1 and anti-bIII-tubulin antibodies.
Electrophysiology
Cultured and acute brain slice whole-cell recordings were obtained with Multiclamp 700B amplifiers (Axon Instruments). For the former, cultured slices from P7-P9 rats (Sprague-Dawley) were infected with indicated lentiviruses at DIV1, and 8-10 days later, whole-cell recordings were obtained simultaneously from an infected and an adjacent uninfected neuron in the CA1 region under visual guidance using epifluorescence and transmitted light illumination. For the latter, acute hippocampal slices were prepared from 21-30-day-old rats or 23-28-day-old mice and placed in a recording chamber perfused with artificial cerebrospinal fluid (ACSF) solution. See Supplemental Experimental Procedures for details.
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